Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DTBZ PET for Parkinson's Disease Diagnosis and Monitoring
NCT01283347Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- May 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Florbenazine F-18 in Parkinson's disease (PD), sponsored by Chang Gung Memorial Hospital. Started May 2010; status: completed.
02
Drugs
Florbenazine F-18
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01283347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01283347.